Triste, Sherlyn B.
HRN: 04-46-44 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFTRIAXONE 1G (VIAL)
06/24/2025
06/30/2025
IV
2g
Od
Infected Breast Mass
Waiting Final Action
07/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/07/2025
07/14/2025
IV
4.5g
Q8hrs
SEPTIC SHOCK
Checking Initial Appropriateness